GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In ...
On Wednesday, the FDA accepted GSK plc’s (NYSE:GSK) marketing application seeking approval for gepotidacin, an ...
pharmaphorum12 小时
FDA set to decide on GSK's gepotidacin antibiotic in March
The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics ...
PharmiWeb8 小时
Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary ...
Application supported by positive results from pivotal phase III EAGLE-2 and EAGLE-3 trials26 March 2025 assigned as action date for FDA decisionGepotidacin could be the first in a new class of oral ...
GSK: FDA Accepts New Drug Application for Gepotidacin
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
GSK Plc: NDA For Gepotidacin Granted Priority Review By FDA - Quick Facts
GSK plc (GSK, GSK.L) announced the FDA has accepted the New Drug Application for gepotidacin, an oral antibiotic with a mechanism of ...
Buy13 小时
GSK's application for urinary tract infections drug is accepted
(Alliance News) - GSK PLC on Wednesday announced that the US Food & Drug Administration has accepted its New Drug Application for gepotidacin. The London-based biopharma company said the FDA has ...
GSK UTI treatment gets FDA priority review status
GSK announced on Wednesday that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for gepotidacin, a first-in-class oral antibiotic, under priority review.
FDA accepts GSK new drug application, Whitbread raises half-year dividend
London open The FTSE 100 is expected to open 17 points higher on Wednesday, having closed down 0.52% on Tuesday at 8,249.28.
GSK's UTI Treatment Gets Accepted for Priority Review by U.S.'s FDA
GSK said that its urinary tract infections treatment gepotidacin has been accepted for priority review by the U.S.'s Food and Drug Administration.
Buy14 小时
CORRECT: Stocks green as UK CPI falls below 2% target
Stocks were higher in London on Wednesday morning, as data showed that UK consumer price inflation fell in September to its lowest rate in more than three years, while producer prices decreased. In ...
MT Newswires on MSN5 小时
European Equities Close Mostly Lower in Wednesday Trading; UK Inflation Cools
The European stock markets closed mostly lower in Wednesday trading as the Stoxx Europe 600 was off 0.15%, the Swiss Market Index declined 0.21%, France's CAC dropped 0.40%, Germany's DAX was down ...
pharmaphorum11 小时
Strategies for commercialising oncology treatments for young adults
The oncology landscape is evolving, with a marked rise in cancer incidence among young adults globally. This challenges the traditional view of cancer as primarily an ailment of the elderly. The ...